Viewing Study NCT05286567


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-01-01 @ 11:19 PM
Study NCT ID: NCT05286567
Status: COMPLETED
Last Update Posted: 2023-01-31
First Post: 2022-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
Sponsor: Aarhus University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module